Baird Maintains Neutral on Tenet Healthcare, Raises Price Target to $280

Benzinga Newsdesk www.benzinga.com Positive 55.0%

Neg 0% Neu 0% Pos 55%

Baird analyst Michael Ha maintains Tenet Healthcare (NYSE:THC) with a Neutral and raises the price target from $210 to $280.